[1] SPRINGER BD. The diagnosis of periprosthetic joint infection. J Arthroplasty. 2015; 30: 908-911.
[2] YOON H, CHO S, LEE D, et al. A review of the literature on culture-negative periprosthetic joint infection: epidemiology, diagnosis and treatment. Knee Surg Relat Res. 2017; 29: 155.
[3] AGGARWAL VK, BAKHSHI H, ECKER NU, et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J Knee Surg. 2014; 27: 399-406.
[4] QIU XS, SUN X, CHEN DY, et al. Application of an articulating spacer in two-stage revision for severe infection after total knee arthroplasty. Orthop Surg.2010; 2(4): 299-304.
[5] 黄水仙,田道法.五味消毒饮临床应用研究进展[J].湖南中医药导报,2002, 8(9): 523-525, 529.
[6] 李兆合.五味消毒饮治疗关节置换术后金黄色葡萄球菌感染机理窥探[J].中医学报,2012, 27(5): 613-614.
[7] 赵辉. 五味消毒饮加减预防全髋关节置换术后感染疗效观察[J]. 山东中医杂志,2015,34(3):187,195.
[8] ZIMMERLI W, TRAMPUZ A, OCHSNER PE. Prosthetic-joint infections. Lancet Infect Dis. 2018;18(12):1308.
[9] PARVIZI J, ALIJANIPOUR P, BARBERI EF, et al. Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections. J Am Acad Orthop Surg. 2015;23 Suppl:S32-43.
[10] 杨晓琴,吴亿晗,白俊毅,等. 五味消毒饮口服液HPLC指纹图谱的建立及6种指标性成分定量测定[J].中草药,2017,48(24): 5151-5157.
[11] 王大忠,孙永强,包伟东. 清创后普朗特液体敷料浸泡联合负压封闭引流和五味消毒饮内服治疗人工髋膝关节置换术后假体周围急性感染[J]. 中医正骨,2016,28(9): 52-54.
[12] LENSKI M, SCHERER MA. Synovial IL-6 as inflammatory marker in periprosthetic joint infections. J Arthroplasty. 2014; 29: 1105-1109.
[13] YOKOTA K, SATO K, MIYAZAKI T, et al. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol. 2014; 66: 121-129.
[14] OSAWA R, WILLIAMS KL, SINGH N. The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications. J Infection. 2011; 62: 119-129.
[15] STAHELOVA A, MRAZEK F, SMIZANSKY M, et al. Variation in the IL1B, TNF and IL6 genes and individual susceptibility to prosthetic joint infection. BMC Immunol. 2012; 13: 25.
[16] RAHMAN MM, MCFADDEN G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2006;2(2):e4.
[17] GUSTAVSSON M. New insights into the structure and function of chemokine receptor:chemokine complexes from an experimental perspective. J Leukoc Biol. 2020. doi: 10.1002/JLB.2MR1219-288R.
[18] BORSIG L, WOLF MJ, ROBLEK M, et al. Inflammatory chemokines and metastasis--tracing the accessory. Oncogene. 2014;33(25): 3217-3224.
[19] ABBOUD D, DAUBEUF F, DO QT, et al. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity. Sci Rep Uk. 2015; 5: 14746.
[20] ANGELINI A, MIYABE Y, NEWSTED D, et al. Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis. Nat Commun. 2018; 9:1461.
[21] LIU Z, GAN L, LIU G, et al. Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice. J Lipid Res. 2016; 57:1373-1381.
[22] CHEN M, CHANG C, HU C, et al. Periprosthetic joint infection caused by gram-positive versus gram-negative bacteria: lipopolysaccharide, but not lipoteichoic acid, exerts adverse osteoclast-mediated effects on the bone. J Clin Med. 2019;8(9). pii: E1289.
[23] GALLO J, SVOBODA M, ZAPLETALOVA J, et al. Serum IL-6 in combination with synovial IL-6/CRP shows excellent diagnostic power to detect hip and knee prosthetic joint infection. PLoS One. 2018;13(6): e0199226.
[24] 顾云,庄重.炎症反射研究新进展[J].中国病理生理杂志,2016,32(12): 2300-2304.
[25] SUGDEN PH, CLERK A. “Stress-responsive” mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 1998; 83: 345-352.
[26] HUSSEIN YM, AMAL S, REZK NA, et al. Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population. Cytokine. 2013; 61: 849-855.
[27] CHIN SS, CHORRO L, CHAN J, et al. Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections. Infect Immun. 2019;87(12). pii: e00482-19.
[28] COVRE LP, DEVINE O, GARCIA DE MOURA R, et al. Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8 T cells in human cutaneous leishmaniasis. Immunology. 2020;159(4):429-440.
[29] VIEIRA CS, MOREIRA OC, BATISTA KKS, et al. The nf-κb inhibitor, imd-0354, affects immune gene expression, bacterial microbiota and infection in midgut. Front Physiol. 2018;9:1189.
[30] SOLAYMANI-MOHAMMADI S, BERZOFSKY JA. Interleukin 21 collaborates with interferon-γ for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection. PLoS Pathog. 2019;15(2):e1007614.
[31] MI-ICHI F, ISHIKAWA T, TAM VK, et al. Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate(APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis. PLoS Negl Trop Dis. 2019;13(8):e0007633.
[32] ELLERIN T, RUBIN RH, WEINBLATT ME. Infections and anti–tumor necrosis factor α therapy. Arthritis Rheum. 2003; 48: 3013-3022.
[33] FONG Y, LOWRY SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990; 55: 157-170.
[34] TAY CH, SZOMOLANYI-TSUDA E, WELSH RM. Control of infections by NK cells. Springer, 1998:193-220.
|